Zoetis Inc. (ZTS): A Deep Dive for the Halal Value Investor

In the quiet pursuit of wealth that aligns with our principles, the discerning Muslim value investor often finds themselves scrutinizing companies that may not immediately spring to mind. We seek not just returns, but Barakah – blessings that come from righteous dealings. Today, we turn our attention to a company that, at first glance, might seem an unlikely candidate for the value investor’s portfolio, yet presents an intriguing case for those who look beyond the obvious. Zoetis Inc. (ZTS), a name perhaps more familiar to veterinarians than stock market enthusiasts, has recently garnered some attention for its potential as a long-term holding. But for us, the questions are twofold: Is it truly halal, and does its current valuation offer a compelling entry point?

Question 1: Is Zoetis Inc. (ZTS) Halal?

The first and most critical filter for any Muslim investor is Shariah compliance. Zoetis Inc. operates in the animal health sector, developing and manufacturing a wide range of animal medicines and vaccines. From a business activity perspective, this is generally considered permissible (halal) as it contributes to the well-being of animals, which is encouraged in Islam. The products themselves are not inherently prohibited.

Furthermore, for those who rely on established screening services, Zoetis Inc. is listed on Musaffa's Shariah-compliant list. This offers an initial layer of comfort regarding its primary business operations. However, as disciplined investors, we must always remember the importance of confirming the financial ratios ourselves before making any investment decision. While the core business is permissible, adherence to specific Shariah financial screening ratios (such as debt-to-equity, interest-bearing income, and non-compliant revenue) is paramount to ensure the investment remains fully halal. An investor should always verify these metrics against current financial statements.

Question 2: Is Zoetis Inc. (ZTS) Worth Owning at This Price?

With the halal question addressed, we move to the realm of value. Zoetis Inc. is currently trading at USD 76.040001. Our analysis suggests that the company is significantly undervalued, trading about 106% below its fair-value band, which ranges from USD 145.4 to USD 168.33. This gap alone demands closer inspection.

Let's delve into Zoetis's quality scores (out of 100):

• Moat: 99 - This score is outstanding. High, steady gross margins of 72% suggest Zoetis possesses a significant competitive advantage that rivals struggle to replicate. This 'moat' protects its market share and profitability, a hallmark of a robust business.
• Predictability: 100 - A perfect score here. Revenue and profits have grown steadily over the last six years, demonstrating a highly dependable track record. This consistency is invaluable for long-term investors seeking stability.
• Profitability: 100 - Another perfect score. For every dollar of sales, Zoetis retains 28% as profit, and it generates an impressive 68% return on shareholders' money (ROE). These figures indicate exceptional operational efficiency and effective capital utilization.
• Growth: 44 - While not as stellar as other metrics, sales have grown approximately 7% a year, and profits about 10% a year. This indicates steady, albeit not explosive, expansion.
• Financial Strength: 42 - This is a point of caution. Zoetis carries heavy debt relative to its size, which introduces more financial risk. While its strong profitability can service this debt, it's a factor to monitor.
• Valuation: 31 - This score indicates the market perceives it as expensive, trading at 13 times earnings. The market expects a lot from Zoetis, which often means future growth is already priced in. However, our fair-value assessment suggests a significant disconnect here, highlighting the potential for undervaluation despite the market's current view.

The combination of an exceptionally strong moat, perfect predictability, and outstanding profitability paints a picture of a high-quality business. Despite the concern regarding financial strength and the market's current 'expensive' tag, the substantial gap between the current price and the fair-value band presents a compelling argument for its undervaluation.

The Takeaway

For the disciplined halal investor, both questions must yield positive answers. A company that is Shariah-compliant but overpriced is a trap; similarly, a deeply undervalued company that fails the halal screening is off-limits. In the case of Zoetis Inc., the core business appears permissible, and it is listed as Shariah-compliant by Musaffa, pending individual ratio verification. Crucially, the fundamental analysis reveals a high-quality business with a strong competitive advantage and predictable, profitable growth, currently trading at a significant discount to its estimated fair value.

As always, the path to Barakah Profits lies in diligent research, adherence to principles, and the patience to let true value emerge. This is not a call to action, but an invitation to further, thoughtful contemplation for those seeking to invest wisely and righteously.

I ran Zoetis Inc. through the Barakah Stock Check app - the halal screen, quality scores and fair-value band above come straight from it. Run any ticker in seconds: barakahprofits.com/stock-check (3 days free). And in the Barakah Watch group we flag halal, wide-moat businesses trading below fair value every day.

Educational only, not financial advice. The halal screen is an automated estimate - confirm with a scholar-reviewed screener before investing. Figures are point-in-time and change.